Site is loading…
Kimmel Cancer Center Thomas Jefferson University is a clinical research site located in Philadelphia, Pennsylvania, United States 19107.
Crixeo Clinical Trials Trust Score: 80/100 (GOOD). This profile has not yet been claimed by the site owner.
Kimmel Cancer Center Thomas Jefferson University has participated in 7 clinical trials with 1 currently active.
Therapeutic areas: HER2-Positive Metastatic Breast Cancer, HER2-Negative Metastatic Breast Cancer, Locally Advanced or Early Breast Cancer.
Sponsors: Hoffmann-La Roche, MedImmune LLC.
Is this your site? Claim your profile and control the information sponsors and patients see.
Browse all research sites in Pennsylvania · View every site in Philadelphia
Trust Score: 80/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Kimmel Cancer Center Thomas Jefferson University has a Crixeo Trust Score of 80/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Kimmel Cancer Center Thomas Jefferson University has 7 clinical trials on record, with 1 currently active. Their work covers HER2-Positive Metastatic Breast Cancer, HER2-Negative Metastatic Breast Cancer, Locally Advanced or Early Breast Cancer.
Kimmel Cancer Center Thomas Jefferson University has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.